Glycopyrrolate Oral Solution Recalled Due to Failed Impurities and Degradation Specifications
Precision Dose Inc. is recalling Glycopyrrolate Oral Solution (1 mg/5 mL) because the product failed to meet specifications for impurities and degradation.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which indicates a remote possibility of adverse health consequences.
Plain-English summary
Precision Dose Inc. is recalling Glycopyrrolate Oral Solution, 1 mg/5 mL, which is distributed nationwide in the United States.
The recall was initiated because the product failed to meet specifications regarding impurities and degradation.
Consumers and healthcare providers should check their inventory for the affected product and contact the manufacturer for further information.
The recalled product
- Product
- GLYCOPYRROLATE (GLYCOPYRROLATE)
- Brand
- GLYCOPYRROLATE
- Manufacturer
- Precision Dose Inc.
- Category
- Drug — Oral Solution
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # 506033
- Exp Date: 11/30/2026.
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · GLYCOPYRROLATE
- ModerateGlycopyrrolate Injection Recall Due to Hair Contamination
FDA (Drugs) · 2026-07-29
- ModerateGlycopyrrolate oral solution recalled after failing impurity and degradation specifications
FDA (Drugs) · 2026-02-04
- ModerateGlycopyrrolate Tablets Recalled Due to Failed Impurities and Degradation Specifications
FDA (Drugs) · 2023-06-28
- ModerateGlycopyrrolate Injection Vials Recalled Due to Labeling Mix-up
FDA (Drugs) · 2023-06-14
- HighGlycopyrrolate Injection, USP recalled for manufacturing practice deviations
FDA (Drugs) · 2023-03-08
Same manufacturer · Precision Dose Inc.
See all →- ModerateAcetaminophen Oral Suspension Recalled Due to Contaminated Raw Ingredient
FDA (Drugs) · 2021-11-17
- ModerateAcetaminophen Oral Suspension Recalled Due to Contaminated Raw Ingredient
FDA (Drugs) · 2021-11-17
- ModeratePrecision Dose Recalls Chlorhexidine Gluconate Oral Rinse Due to cGMP Deviations
FDA (Drugs) · 2021-01-20
- SeverePrecision Dose Recalls Ranitidine Oral Solution Due to NDMA Impurity
FDA (Drugs) · 2020-03-18
- ModeratePrecision Dose Recalls Subpotent Carbamazepine Oral Suspension Unit Dose Cups
FDA (Drugs) · 2017-11-08
Same hazard · impurities
See all →- LowDabigatran Etexilate Capsules Recalled Due to Impurity Specification Failure
FDA (Drugs) · 2026-08-05
- ModerateMethohexital Sodium for Injection Recalled for Failed Impurities and Degradation Specifications
FDA (Drugs) · 2026-07-15
- ModerateMethohexital Sodium 100 mg/10 mL Compounded Drug Recalled Nationwide
FDA (Drugs) · 2026-07-15
- LowFexofenadine Hydrochloride Tablets 180 mg Recalled for Impurities
FDA (Drugs) · 2026-07-08
- ModerateAlyacen 7/7/7 birth control tablets failed total impurities specification
FDA (Drugs) · 2026-06-24